12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort studyRiccardo De Giorgi, Maxime Taquet, Philip J. Cowen et al.|EClinicalMedicine|2024Cited by 59
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disordersRiccardo De Giorgi, Catherine J. Harmer, Ana Ghenciulescu et al.|Nature Mental Health|2025Cited by 58
Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trialGeorgina Russell, Stafford L. Lightman, Marcus R. Munafò et al.|Journal of Internal Medicine|2023Cited by 26